Exagen Inc. (XGN)

NASDAQ

$8.27

$+0.02

(+0.19%)

Pre-Market

Exagen Inc. (XGN) Live Price Chart

Last updated: ⁦2026-10-13 12:35:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Exagen Inc. (XGN) operates in the SERVICES-MEDICAL LABORATORIES sector and is listed on NASDAQ. The stock is currently priced at $8.27, with a market capitalisation of $203.98M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.59 to $12.23. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$203.98M
Open	$8.25
Day's High	$29.86
Day's Low	$1.30
Previous Close	$8.25
Volume	1.21K
Average Volume	332.34K
P/E Ratio	--
52-Week High	$12.23
52-Week Low	$2.59
Dividend Yield	--
Earnings Date	--

Exagen Inc. (XGN) Pre-Market Stock Price

Exagen Inc. (XGN) is trading at $8.27 in pre-market trading as of 2026-10-13 12:09:00, up 0.18% ($0.02) from the previous close of $8.25

Pre-market trading shows how investors are pricing XGN before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.

Exagen Inc. (XGN) 7-Day Stock Price Change

Over the past seven days, Exagen Inc. (XGN) moved from $8.17 to $8.27, representing a gain of 1.16% ($0.10).

The stock traded between $7.78 and $8.70 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.

The average daily volume was 318.80 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

XGN 52-Week Price Position

Position in Range: 58.9%

52W Low$2.59

52W High$12.23

XGN is currently trading at $8.27, placing it 58.9% of the way from its 52-week low of $2.59 to its 52-week high of $12.23. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Exagen Inc. (XGN)?

Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.

Exagen Inc. Information

Industry	SERVICES-MEDICAL LABORATORIES
Employees	220
Exchange	NASDAQ
Company Website	https://www.exagen.com

How to Buy Exagen Inc. (XGN) Stock on MEXC

Eligible investors can buy real shares of Exagen Inc. (XGN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for XGN and Place Your Order

Open the RealStocks trading page and search for XGN. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Exagen Inc. (XGN) stock price today?

Exagen Inc. (XGN) is currently trading at $ 8.27, up 0.18% ($0.02) from the previous close of $ 8.25. Intraday prices update in real time during regular trading hours.

2.Is XGN stock going up or down today?

As of 2026-10-13 12:09:00, XGN is trading at $ 8.27, up 0.18% ($0.02) from its previous close of $ 8.25. The stock has traded between $ 1.30 and $ 29.86 during today’s regular session. Past price movements do not guarantee future results.

3.What is XGN pre-market price?

As of 2026-10-13 12:09:00, XGN is trading at $ 8.27 in pre-market trading, up 0.18% ($0.02) from the previous close of $ 8.25. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is XGN after-hours price?

As of 2026-10-13 12:09:00, XGN is trading at $ 8.26 in after-hours trading, up 0.06% ($0.01) from the regular-session close of $ 8.25. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is XGN stock trading now?

XGN trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does XGN sit relative to its 52-week high and low?

Over the past 52 weeks, XGN has traded between a low of $ 2.59 and a high of $ 12.23. At $ 8.27, the stock is positioned 58.9% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Exagen Inc. in?

Exagen Inc. (XGN) operates in the SERVICES-MEDICAL LABORATORIES sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Exagen Inc.'s market capitalisation and where is it listed?

Exagen Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 203.98M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is XGN valued in terms of P/E ratio and EPS?

XGN trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.78. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Exagen Inc. pay a dividend?

Exagen Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.